Clinical Investigations of High-Risk Medical Devices in India, Germany and Canada
Bibliographic record
Abstract
High-risk medical devices, including implants and life-sustaining technologies, play a critical role in healthcare but also present substantial regulatory and clinical challenges. This paper provides a comparative analysis of India, Germany, and Canada, three countries representing different regulatory maturities and healthcare contexts. Using a qualitative comparative approach, the study reviewed regulatory policy documents, peer-reviewed literature, and international reports (2019–2025) to examine approval pathways, evidence generation, ethics oversight, operational barriers, and post-market surveillance mechanisms for high-risk devices. Results reveal that India, governed by the Medical Devices Rules (2017), has made progress toward harmonization but continues to struggle with infrastructure gaps, uneven ethics committee performance, and weak materiovigilance participation. Germany, under EU MDR, stands out for its rigor in clinical evidence requirements but is hampered by bottlenecks in notified bodies, compliance fatigue, and limited transparency for legacy devices. Canada demonstrates balanced oversight and innovation, with strong ethics and pioneering use of real-world evidence, though high costs and inter provincial fragmentation complicate trial efficiency. Despite differences, shared challenges include regulatory ambiguity, transparency gaps, difficulties in generating robust evidence, and incomplete post-market surveillance systems. The study concludes that global harmonization, stronger oversight mechanisms, and cross-country learning are essential to ensure safe, effective, and timely access to high-risk medical devices worldwide.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.013 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.003 | 0.005 |
| Science and technology studies | 0.003 | 0.004 |
| Scholarly communication | 0.003 | 0.000 |
| Open science | 0.001 | 0.002 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".